Phreesia Shareholder Class Action Notice
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 16 2026
0mins
Source: PRnewswire
- Lawsuit Background: The Gross Law Firm has issued a notice to shareholders of Phreesia, Inc. (NYSE:PHR), encouraging those who purchased shares during the class period from May 8, 2025, to March 30, 2026, to contact the firm regarding potential lead plaintiff appointment.
- Allegations: The complaint alleges that Phreesia misled investors by providing overly positive statements while concealing significant adverse facts about slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment.
- Financial Impact: On March 30, 2026, Phreesia announced a significant reduction in revenue growth projections for fiscal year 2027, attributing the shortfall to macroeconomic factors and weakened pharmaceutical marketing commitments, resulting in a stock price decline from $11.41 per share on March 30, 2025, to $8.38 per share on March 31, 2026, a drop of approximately 27%.
- Shareholder Next Steps: Shareholders must register for the class action by July 13, 2026, and upon registration, they will receive updates throughout the case lifecycle, with no cost or obligation to participate.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PHR
Wall Street analysts forecast PHR stock price to rise
12 Analyst Rating
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 9.130
Low
24.00
Averages
29.09
High
35.00
Current: 9.130
Low
24.00
Averages
29.09
High
35.00
About PHR
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Phreesia Shareholder Class Action Notice
- Class Action Deadline: Shareholders of Phreesia, Inc. must apply to be lead plaintiffs in the class action by July 13, 2026, if they purchased stock between May 8, 2025, and March 30, 2026, potentially entitling them to compensation.
- Fee Structure: Shareholders participating in the class action incur no upfront costs, as attorney fees will be covered through a contingency fee arrangement, thereby reducing financial barriers and encouraging broader participation.
- Lawsuit Allegations: The lawsuit claims that Phreesia made false or misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, which led to investor losses.
- Law Firm Credentials: The Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, highlighting its expertise and success rate, prompting investors to carefully select experienced legal counsel.
See More
Phreesia Investors Class Action Reminder
- Lawsuit Background: On March 30, 2026, Phreesia announced significantly lowered revenue growth projections for fiscal 2027, resulting in a 26.6% drop in stock price to $8.38 per share the following day, causing substantial losses for investors.
- False Information Allegations: The complaint alleges that throughout the class period, the company misled investors by projecting confidence in its long-term growth outlook while downplaying risks associated with slowing growth in its Network Solutions segment, putting the 2027 revenue target at risk.
- Investor Action Required: Affected investors must file a lead plaintiff motion by July 13, 2026, to participate in the class action lawsuit and seek recovery for losses incurred due to the company's misleading statements, thereby protecting their legal rights.
- Legal Consultation Information: Glancy Prongay Wolke & Rotter LLP offers legal consultation, and investors can contact them via phone or email to learn more about the class action and how to participate.
See More
Investigation into Phreesia, Inc. Shareholder Rights
- Shareholder Rights Investigation: Bernstein Liebhard LLP is investigating whether certain directors and officers of Phreesia, Inc. breached their fiduciary duties to the company, affecting shareholders who purchased stock prior to May 8, 2025, which could impact corporate governance and shareholder trust.
- Legal Consultation Opportunity: Shareholders holding Phreesia stock are encouraged to contact Bernstein Liebhard LLP to discuss their legal rights and options, potentially providing a pathway for seeking compensation and enhancing accountability for the company's management.
- Proven Track Record: Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients, demonstrating strong capabilities in protecting investor rights, which may attract more shareholders to participate in the investigation and seek legal support.
- Reputable Law Firm: The firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years, indicating its reputation and influence in the legal field, which may bolster shareholder confidence in the investigation.
See More
Notice of Class Action Lawsuit for Phreesia Shareholders
- Class Action Notice: Rosen Law Firm reminds investors who purchased Phreesia stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing the true state of its Network Solutions segment's weakened pharmaceutical marketing commitments, which led to investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, being ranked No. 1 by ISS Securities Class Action Services in 2017, showcasing its expertise and success in this field.
- Investor Action Recommendations: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, emphasizing the importance of selecting qualified legal counsel to protect their interests in the lawsuit and avoid inexperienced intermediaries.
See More
Faruqi & Faruqi Encourages Phreesia Investors to Reach Out
- Legal Investigation: Faruqi & Faruqi LLP is investigating potential claims against Phreesia, Inc., particularly for investors who purchased securities between May 8, 2025, and March 30, 2026, urging them to seek lead plaintiff status by the July 13, 2026 deadline to represent other investors in a federal securities class action.
- False Statement Allegations: The lawsuit alleges that Phreesia and its executives made overly optimistic statements to investors while failing to disclose weakening revenue streams, leading to significant financial losses for investors who purchased securities at artificially inflated prices.
- Stock Price Plunge: On March 30, 2026, Phreesia announced a significant reduction in its revenue growth projections for fiscal year 2027, causing its stock price to drop from $11.41 to $8.38 per share, a decline of approximately 27%, reflecting market pessimism regarding the company's future outlook.
- Investor Rights Protection: Faruqi & Faruqi encourages all investors who purchased Phreesia stock during the class period and suffered losses to contact them to discuss their legal rights, emphasizing that investors can still share in any recovery even if they do not seek lead plaintiff status.
See More
Phreesia Faces Class Action Lawsuit for Misleading Statements
- Class Action Reminder: The Schall Law Firm alerts investors of a class action lawsuit against Phreesia for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between May 8, 2025, and March 30, 2026, with a deadline to contact the firm by July 13, 2026.
- False Statement Allegations: The complaint alleges that Phreesia misled the market by claiming a reliable long-term growth outlook despite uncertainties that could jeopardize revenue targets, resulting in investor losses when the truth emerged.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations and encourages affected investors to join the lawsuit for potential recovery, highlighting its specialization in securities class actions and shareholder rights litigation to protect investor interests.
- Lawsuit Status Explanation: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, emphasizing the importance of taking action to avoid being an absent class member.
See More
Phreesia Shareholder Class Action Notice
- Class Action Deadline: Shareholders of Phreesia, Inc. must apply to be lead plaintiffs in the class action by July 13, 2026, if they purchased stock between May 8, 2025, and March 30, 2026, potentially entitling them to compensation.
- Fee Structure: Shareholders participating in the class action incur no upfront costs, as attorney fees will be covered through a contingency fee arrangement, thereby reducing financial barriers and encouraging broader participation.
- Lawsuit Allegations: The lawsuit claims that Phreesia made false or misleading statements during the class period, concealing adverse facts such as weakened pharmaceutical marketing commitments in its Network Solutions segment, which led to investor losses.
- Law Firm Credentials: The Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, highlighting its expertise and success rate, prompting investors to carefully select experienced legal counsel.
See More
Phreesia Investors Class Action Reminder
- Lawsuit Background: On March 30, 2026, Phreesia announced significantly lowered revenue growth projections for fiscal 2027, resulting in a 26.6% drop in stock price to $8.38 per share the following day, causing substantial losses for investors.
- False Information Allegations: The complaint alleges that throughout the class period, the company misled investors by projecting confidence in its long-term growth outlook while downplaying risks associated with slowing growth in its Network Solutions segment, putting the 2027 revenue target at risk.
- Investor Action Required: Affected investors must file a lead plaintiff motion by July 13, 2026, to participate in the class action lawsuit and seek recovery for losses incurred due to the company's misleading statements, thereby protecting their legal rights.
- Legal Consultation Information: Glancy Prongay Wolke & Rotter LLP offers legal consultation, and investors can contact them via phone or email to learn more about the class action and how to participate.
See More
Investigation into Phreesia, Inc. Shareholder Rights
- Shareholder Rights Investigation: Bernstein Liebhard LLP is investigating whether certain directors and officers of Phreesia, Inc. breached their fiduciary duties to the company, affecting shareholders who purchased stock prior to May 8, 2025, which could impact corporate governance and shareholder trust.
- Legal Consultation Opportunity: Shareholders holding Phreesia stock are encouraged to contact Bernstein Liebhard LLP to discuss their legal rights and options, potentially providing a pathway for seeking compensation and enhancing accountability for the company's management.
- Proven Track Record: Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients, demonstrating strong capabilities in protecting investor rights, which may attract more shareholders to participate in the investigation and seek legal support.
- Reputable Law Firm: The firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years, indicating its reputation and influence in the legal field, which may bolster shareholder confidence in the investigation.
See More
Notice of Class Action Lawsuit for Phreesia Shareholders
- Class Action Notice: Rosen Law Firm reminds investors who purchased Phreesia stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to participate in the class action and seek compensation.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing the true state of its Network Solutions segment's weakened pharmaceutical marketing commitments, which led to investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, being ranked No. 1 by ISS Securities Class Action Services in 2017, showcasing its expertise and success in this field.
- Investor Action Recommendations: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, emphasizing the importance of selecting qualified legal counsel to protect their interests in the lawsuit and avoid inexperienced intermediaries.
See More
Faruqi & Faruqi Encourages Phreesia Investors to Reach Out
- Legal Investigation: Faruqi & Faruqi LLP is investigating potential claims against Phreesia, Inc., particularly for investors who purchased securities between May 8, 2025, and March 30, 2026, urging them to seek lead plaintiff status by the July 13, 2026 deadline to represent other investors in a federal securities class action.
- False Statement Allegations: The lawsuit alleges that Phreesia and its executives made overly optimistic statements to investors while failing to disclose weakening revenue streams, leading to significant financial losses for investors who purchased securities at artificially inflated prices.
- Stock Price Plunge: On March 30, 2026, Phreesia announced a significant reduction in its revenue growth projections for fiscal year 2027, causing its stock price to drop from $11.41 to $8.38 per share, a decline of approximately 27%, reflecting market pessimism regarding the company's future outlook.
- Investor Rights Protection: Faruqi & Faruqi encourages all investors who purchased Phreesia stock during the class period and suffered losses to contact them to discuss their legal rights, emphasizing that investors can still share in any recovery even if they do not seek lead plaintiff status.
See More
Phreesia Faces Class Action Lawsuit for Misleading Statements
- Class Action Reminder: The Schall Law Firm alerts investors of a class action lawsuit against Phreesia for violations of §§10(b) and 20(a) of the Securities Exchange Act, concerning securities purchased between May 8, 2025, and March 30, 2026, with a deadline to contact the firm by July 13, 2026.
- False Statement Allegations: The complaint alleges that Phreesia misled the market by claiming a reliable long-term growth outlook despite uncertainties that could jeopardize revenue targets, resulting in investor losses when the truth emerged.
- Legal Consultation Opportunity: The Schall Law Firm offers free consultations and encourages affected investors to join the lawsuit for potential recovery, highlighting its specialization in securities class actions and shareholder rights litigation to protect investor interests.
- Lawsuit Status Explanation: The class action has not yet been certified, meaning investors are not represented by an attorney until certification occurs, emphasizing the importance of taking action to avoid being an absent class member.
See More
